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CASE REPORT
Paraneoplastic pemphigus (PNP), or paraneoplas-
tic autoimmune multiorgan syndrome (PAMS),
was formally characterized by Anhalt et al in 1990
in patients with autoimmune mucocutaneous
disease with underlying neoplasia.1,2 PNP has
both mucocutaneous and systemic presentations.
Ocular, nasal, oral, upper gastrointestinal, respi-
ratory and genital epithelium may be involved
with painful erosions. Polymorphous lesions,
such as pemphigus-like, bullous pemphigoid
(BP)-like, erythema multiforme-like, graft-versus-
host disease-like, or lichen planus-like macules,
papules, plaques, and blisters may develop on
the skin.2–5 Histologic features of PNP include
epidermal acantholysis, suprabasal cleft or blister,
dyskeratotic keratinocytes, basal vacuolization and
epidermal exocytosis of inflammatory cells.6 Mole-
cular weights of target antigens for PNP have been
shown to be 250, 230, 210, 190 and 170 kDa.2 The
mortality rate is more than 90%, and 30% of pa-
tients have the complication of respiratory failure
with features of bronchiolitis obliterans (BO).3
PNP-associated underlying neoplasms in the
West include non-Hodgkin’s lymphoma (42%),
chronic lymphocytic leukemia (29%), Castleman’s
disease (10%), thymoma (6%), retroperitoneal
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sarcomas (6%), and Waldenström macroglobu-
linemia (6%).2,4 Kaplan et al, who reviewed 163
cases of PNP reported between 1990 and 2003,
demonstrated that hematologic neoplasms or
disorders were diagnosed in 84% of the cases
and 16% of all cases were associated with non-
hematologic neoplasms, such as epithelial origin-
carcinoma (8.6%), mesenchymal origin-sarcoma
(6.2%), and malignant melanoma (0.6%).7 In
China, 14 cases of PNP have been reported.4 Only
14% of the reported tumors associated with PNP
were non-Hodgkin’s lymphoma, and 71% were
probably Castleman’s disease.4 In Taiwan, a pa-
tient with esophageal squamous cell carcinoma
was reported.8 Although B-cell lymphoma is the
most commonly associated underlying malig-
nancy,9 only one case associated with splenic 
B-cell lymphoma has been reported.10 We herein
report a patient who presented with symptoms
and signs of PNP and who was found to have an
underlying splenic B-cell lymphoma, who later
developed BO, resulting in death.
Case Report
This 44-year-old previously healthy woman pre-
sented with a 1- to 2-week history of multiple oral
ulcers and conjunctivitis. Several erosions on the
trunk and upper limbs ensued for several days
(Figure 1A). Skin biopsy on the back revealed
suprabasal acantholysis, lichenoid lymphohisti-
ocytic infiltration, and focal vacuolar changes of
the dermal–epidermal junction (Figure 1B). Direct
immunofluorescence (DIF) study showed granu-
lar deposition of C3 at the basement membrane
zone (BMZ) and deposition of IgG and C1q at the
intercellular space (ICS) in the epidermis
(Figures 1C and 1D). Abdominal echography and
computed tomography (CT) revealed a huge
splenic tumor (Figure 2A). Splenectomy was per-
formed. Pathology showed mixed small cleaved
and large B-cell lymphoma (CD20+/CD3−/CD5−/
CD43−bcl-2+ weakly) (Figure 2B). Two months
after presentation, chemotherapy with COP (cy-
clophosphamide, vincristine and prednisolone)
regimen was instituted. Three courses of anti-CD20
and COP were given in the consecutive 3 months,
and the cutaneous lesions healed gradually. How-
ever, due to deteriorating general condition with
severe chemotherapy-related complications and
poor performance status, this regimen was dis-
continued after the third course of anti-CD20.
Seven months after presentation, collapse of
the right lower lobe (RLL) of the lung was shown
on chest X-ray. Asthma and CO2 retention devel-
oped thereafter despite the patient having no past
history of asthma. Inhaled ipratropium bromide,
terbutaline sulfate with intravenous hydrocortisone
and aminophylline were given. Chest CT showed
collapse of bilateral lower lungs with ground glass
opacity in the right middle lobe (RML), RLL and
anterior left upper lobe. Lung function test showed
severe mixed type ventilatory defect without re-
sponse to bronchodilator therapy. Her respira-
tory function continued to deteriorate, and she
became O2-dependent. Rehabilitation for respira-
tory training was arranged and intravenous steroid
and inhaled bronchodilators were continued.
Eleven months after presentation, she was in-
tubated for respiratory distress. High-resolution
CT disclosed collapse of the RLL and atelectasis
of the RML. Hyperinflation of the lungs was also
noted (Figure 3A). Video-associated thoracosco-
pic surgery for wedge resection of the RML and
the RLL was performed. Pathology showed dif-
fuse bronchioloectasis with BO evidenced with
Masson and elastic stains (Figures 3B–D). DIF
study showed granular depositions of IgG, IgA,
IgM, fibrinogen, C3 and C1q at the BMZ of the
terminal bronchioles (Figure 4). One month after
the operation, the patient died due to respiratory
failure despite aggressive resuscitation.
Discussion
Diagnostic criteria for PNP have been pro-
posed.9,11,12 The major criteria include polymor-
phous mucocutaneous eruption, concurrent
neoplasia, and characteristic serum immuno-
precipitation findings. The minor ones include
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immunoreactants at the BMZ and ICS on DIF,
positive indirect immunofluorescence staining at
the ICS with rat bladder as substance, and acan-
tholysis in at least one anatomic site of involve-
ment. PNP should be considered if all three major
or two major and two minor criteria are met.11,12
As for our case, although the result of immu-
noblotting was not obtained due to unavailable
facility at that time, the diagnosis of PNP was 
established based on fulfillment of at least two
major and two minor criteria.
Several hypotheses for the pathophysiology of
PNP have been postulated, such as tumor antigen-
caused cross reaction, autoimmune responses in-
duced by tumor-produced plakin proteins, and
autoimmune-related epitope spreading.1,4 The
antibodies to epithelium show molecular masses
of 250, 230, 210, 190 and 170 kDa.2 These pro-
teins were recognized as desmoplakin (DP) I, BP
antigen I, DP II/envoplakin (ENV), periplakin
(PER), and a transmembrane cell-surface protein
of unknown nature, respectively.1,2,12 DP I, BP
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Figure 1. (A) Polymorphic cutaneous eruption appeared several days after hospitalization; inset: severe oral ulceration
with conjunctivitis (arrow) and nasal mucosal involvement. (B) Histopathology showed suprabasal cleft, epidermal acan-
tholysis, and vacuolar interface change (hematoxylin & eosin; original magnification, 400×). Direct immunofluorescence
examination showed: (C) granular deposition of C3 in the basement membrane zone (original magnification, 400×); 
(D) IgG deposition in the intercellular space (original magnification, 400×).
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antigen I, DP II, ENV and PER all belong to the
plakin family of proteins, which are involved in
the organization of intermediate filaments and
cytoskeletal architecture and play important roles
in the anchorage of the cytoskeleton to filament
attachment sites on the plasma membrane.2,13
Besides, desmogleins (Dsg) 1 and 3 were also






Figure 2. (A) Abdominal computed tomography revealed a huge splenic tumor. (B) Histopathology showed mixed small
cleaved and large B-cell lymphoma (hematoxylin & eosin; original magnification, 400×).
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Figure 3. (A) High-resolution computed tomography revealed atelectasis in the right middle lobe, total collapse in the
right lower lobe, and hyperinflation in bilateral lungs. (B) Pulmonary histopathology showed bronchiolitis obliterans with
obstruction of small airways (hematoxylin & eosin; original magnification, 33×). (C) Masson stain suggested active fibrosis
(original magnification, 33×). (D) The obstructed lumen was proven to be terminal bronchiole on elastic stain (original
magnification, 33×).
protein family and mediate cell–cell adhesion at
desmosomal junctions.12
The prognosis of PNP is very poor even with
eradication of the associated tumor.2 Compli-
cations of severe respiratory distress and BO as-
sociated with IgG deposition on the bronchial
epithelium is not uncommon. The mainstay of
therapy is palliative immunosuppression and/or
intravenous immunoglobulin therapy, which,
however, is usually ineffective.2 The mortality
rate of PNP is up to 90%, and the causes of death
are mainly due to complications associated with
immunosuppression, such as sepsis and multior-
gan failure. However, about 30% of patients die
of respiratory failure with features of BO.3,14
Constrictive BO is a relatively rare disease that
has been described in allograft recipients, and 
in patients with autoimmune diseases, Stevens-
Johnson syndrome, primary biliary cirrhosis and
exposure to fumes of tobacco or toxic agents.
Immunologic response may play a role in the
pathogenesis of constrictive BO.15 The pathogen-
esis of PNP-associated BO is not clear. Healthy
human bronchial epithelium expresses DP I, BP
antigen I, DP II, ENV, PER and plectin, but neither
the 170-kDa PNP antigen nor desmoglein 3.3,13
Tissue-bound autoantibodies are considered 
important to the development of epithelial cell
detachment and inflammation in the bronchial
epithelium.11 In PNP patients with respiratory com-
plications, the deposition of IgG has been demon-
strated on bronchial epithelial cell surfaces and/or
basement membranes.3,13,14,16 Acantholysis-like
lesions were also shown in the bronchial pseudo-
stratified columnar epithelium.3 For our patient,
deposits of IgG, IgA, IgM, fibrinogen, C3 and
C1q in respiratory epithelia support the above
pathophysiologic mechanism. The reaction of
autoantibodies to the respiratory epithelium could
be triggered by exposure of intracellular plakin
proteins by cell-mediated cytotoxic mechanisms.17
CD8+ T lymphocytes may play a key role in the
progression of BO.18
In summary, we described a rare case of splenic
B-cell lymphoma complicated with PNP and BO.
The patient died 12 months later as a result of
respiratory failure despite intensive immunosup-
pression and respiratory care. Consulting a der-
matologist for sudden unusual polymorphic
mucocutaneous manifestation is necessary and 
it may prompt work-up for possible underlying
neoplasia. In addition, the association of PNP and
BO must be kept in mind. If respiratory distress
develops, it is mandatory to obtain quick and com-
plete suppression of acute-phase inflammation
to prevent severe bronchiolar inflammation that
will progress to irreversible fibrosis and BO.13
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